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INTRODUCTION
A primary concern of the O’Neill Institute is global health.1
The website of the Georgetown University Law Center asserts the importance
of global health law, claiming that:
Health laws and policies are increasingly transnational in the modern era.
Trade, commerce, travel, environment, war, and terrorism transcend bound-
aries and profoundly impact individual and communal health. Protecting the
public’s health and improving individual health outcomes increasingly in-
volve national and international innovation and collaboration through legal
systems.2
A second focus of the O’Neill Institute is health care financing and organiza-
tion.3 The mission of the Institute’s Financing and Organization Center is to
“improve health care systems by focusing on the inefficiencies associated with
existing organizational, financing and regulatory structures.”4 The Center’s use
of the term “health care systems” suggests that its focus is not narrowly
domestic, but that it might address health care financing and organization more
* Robert L. Willett Family Professor of Law, Washington and Lee University. © 2008, Timothy
Stoltzfus Jost. The author wishes to thank the Frances Lewis Law Center for research support.
1. See O’Neill Institute for National and Global Health Law, http://www.law.georgetown.edu/
oneillinstitute/centers.html (last visited Oct. 25, 2007).
2. Master of Laws: Global Health Law, http://www.law.georgetown.edu/graduate/globalhealth.htm
(last visited Oct. 25, 2007).




The question addressed by this Essay is whether synergy is possible between
these research concentrations. Is it useful to think about global health care
financing law? The conclusion of this Essay is that law can in fact make a
modest contribution at the global level to addressing the issues that face health
care financing systems. This contribution is limited, however, first, because
health care financing systems are peculiarly national rather than global in their
orientation, and second, because even at the domestic level, law has only a
secondary role to play in the design, operation, and reform of health care
financing systems.
I. GLOBAL HEALTH LAW AND HEALTH CARE FINANCE
The global reach of other forms of health law studied by the Center is
obvious. The application of the notion of global health law to public health law,
for example, seems quite straightforward. Epidemics and hazardous products
move easily across national boundaries. International conventions, such as the
International Health Regulations, exist to permit countries to work together in
addressing these threats.5 Some forms of health care regulation also take place
at the global level. Regulation of drugs, for example, is increasingly coordinated
through the International Conference on Harmonization of Technical Require-
ments for Registration of Pharmaceuticals for Human Use (ICH) guidelines,6
while regulation of biomedical research looks to international standards like the
Declaration of Helsinki or the Council for International Organizations of Medi-
cal Sciences (CIOMS) guidelines.7
It is more difficult, however, to describe the meaning of global health law for
health care financing systems. Health care financing is indisputably of great
importance. The United States spent almost one sixth of its Gross Domestic
Product (GDP) on health care in 2003; this was more than it spent on food,
transportation, housing, or any other expenditure.8 Even with this level of
spending, 47 million Americans—15.8% of the population—did not have health
5. See David P. Fidler & Lawrence O. Gostin, The New International Health Regulations: An
Historic Development for International Law and Public Health, 34 J.L. MED. & ETHICS 85, 86, 93
(2006) (asserting that “[t]he transformational nature of the new [International Health Regulations]
create[s] a regime that has the potential to contribute significantly to the general global governance
mission of improving national and international health,” but recognizing that that new regulations are
not a “‘magic bullet’ for global health problems”).
6. See International Conference on Harmonization of Technical Requirements for Registration of
Pharmaceuticals, Revised ICH Terms of Reference, http://www.ich.org/cache/html/581-272-1.html (last
visited Aug. 20, 2007).
7. See THE ETHICS OF RESEARCH INVOLVING HUMAN SUBJECTS: FACING THE 21ST CENTURY 433, 501
(Harold Y. Vanderpool ed., 1996).
8. Gerard F. Anderson et al., Health Care Spending and Use of Information Technology in OECD
Countries, 25 HEALTH AFF. 819, 819, 820 exhibit 1 (2006); U.S. CENSUS BUREAU, STATISTICAL ABSTRACT
OF THE UNITED STATES, 2007, at 435 tbl.656 (126th ed. 2006), available at http://www.census.gov/statab/
www/.
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insurance in 2006.9 The United States spends more on health care than does any
other country, though health care costs are a major concern in virtually all
countries. The median OECD country spent 8.4% of its GDP on health care in
2003, while several countries, including France, Germany, and Switzerland now
spend 10% or more of their GDP on health care.10 In every OECD country,
health care spending is increasing at a rate that exceeds GDP growth.11 While
all other OECD countries provide universal or nearly universal access to health
insurance, prompt access to some services is a real problem in a number of
countries.12 Developing countries spend less of their GDP on health care, but
face severe problems of access to health care, including access to basic health
care and services and public health protection.13
It would seem, therefore, that a global collaboration to study law as it
concerns health care financing could be valuable in addressing common con-
cerns. From the outset, however, this field of study faces two problems: the
peculiarly domestic nature of health care financing systems and the limited role
of law in health care finance.
II. GLOBAL HEALTH CARE FINANCING? HEALTH CARE FINANCING LAW?
Health care financing systems are peculiarly national in their orientation.
Indeed, many systems, like our Medicaid program or the Canadian or Swiss
health care systems, are even administered primarily at subnational regional
levels.14 National systems can, of course, be classified for analytic purposes—
for example as social insurance or as general revenue-funded national health
service systems.15 But the French, German, and Dutch systems, traditionally
classified as social insurance systems, are almost as unlike each other as they
are unlike the Swedish, Canadian, Spanish, Irish, and English general revenue-
9. CARMEN DENAVAS-WALT, BERNADETTE D. PROCTOR & JESSICA SMITH, U.S. CENSUS BUREAU, INCOME,
POVERTY, AND HEALTH INSURANCE COVERAGE IN THE UNITED STATES: 2006, at 18 (2007), available at
http://www.census.gov/prod/2007pubs/p60-233.pdf.
10. Anderson et al., supra note 8, at 820.
11. Chapin White, Health Care Spending Growth: How Different Is the United States from the Rest
of the OECD?, 26 HEALTH AFF. 154, 154, 157 exhibit 2 (2007).
12. See KAREN DAVIS ET AL., THE COMMONWEALTH FUND, MIRROR, MIRROR ON THE WALL: AN
INTERNATIONAL UPDATE ON THE COMPARATIVE PERFORMANCE OF AMERICAN HEALTH CARE 15 (2007),
available at http://www.commonwealthfund.org/usr_doc/1027_Davis_mirror_mirror_international_
update_final.pdf?section4039.
13. See Symposium, Global Health Financing, 26 HEALTH AFF. 918 (2007); George Schieber &
Akiko Maeda, Health Care Financing and Delivery in Developing Countries, 18 HEALTH AFF. 193, 198
& exhibit 4 (1999).
14. See EUROPEAN OBSERVATORY ON HEALTH CARE SYS., HEALTH CARE SYSTEMS IN TRANSITION:
SWITZERLAND 14–15 (2000); GREGORY P. MARCHILDON, EUROPEAN OBSERVATORY ON HEALTH SYS. &
POLICIES, HEALTH SYSTEMS IN TRANSITION: CANADA 26–27 (Sara Allin & Elias Mossialos eds., 2005).
15. See TIMOTHY STOLTZFUS JOST, HEALTH CARE AT RISK: A CRITIQUE OF THE CONSUMER-DRIVEN
MOVEMENT 167–71 (2007) (stating that “[m]ost attempts to categorize the world’s various systems begin
with a division between social insurance and national health service models,” but finding that “[t]his
traditional approach to classification is problematic”).
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funded national health service systems, which are also each unique.16 Indeed,
the provincial health care system of Ontario differs in significant ways from that
of Quebec,17 as does the national health service of Scotland from that of
England.18 The health care systems of developing countries also differ signifi-
cantly among themselves. The United States, of course, is absolutely sui
generis. Each nation’s health care system is the product of that nation’s peculiar
history and politics.19
A second and in some ways more significant issue is the minimal role that
law generally plays in health care finance systems. If health care financing
systems are primarily products of the unique history and politics of particular
countries, the most useful disciplines for understanding how health care systems
have evolved would seem to be history and political science. The most useful
disciplines for considering how to improve the functioning of health care
systems, on the other hand, are arguably health economics, health services
research, and health policy. But what is the role of law? Do—or can—law,
lawyers, or legal institutions make any significant contribution to the organiza-
tion or reform of health care finance?
Public health care systems are, of course, constructed on legal frameworks—
16. See, e.g., Special Issue, Analysing the Impact of Health System Changes in the EU Member
States, 14 HEALTH ECON. S1 (2005) (describing the health care systems of a variety of European
countries). The primary difference between the social insurance model of health care finance and the
general revenue-funded model is that social insurance systems are generally funded by employee (and
often employer) “contributions,” essentially payroll taxes, while general revenue-funded national health
services are funded by income, consumption, or other general taxes. JOST, supra note 15, at 168.
Beyond this, financing is often administered in social insurance systems by “quasi-public social
insurance funds,” and services are more likely to be provided by private professionals and providers. Id.
National health insurance funds are more likely to be administered by the government and at least some
services are likely to be publicly provided. Id. Region-based national health services systems like those
of Canada or the Scandinavian countries operate quite differently from more centralized systems like
that of England. Social insurance systems also differ in important respects, such as in the degree to
which the program is in fact funded by general taxes or the degree of independence and the number of
governing sickness funds. See Rienhard Busse, Richard B. Saltman & Hans F.W. Dubois, Organization
and Financing of Social Health Insurance Systems: Current Status and Recent Policy Developments, in
SOCIAL HEALTH INSURANCE SYSTEMS IN WESTERN EUROPE 33, 33–40, 47–50 (Richard B. Saltman,
Reinhard Busse & Josep Figueras eds., 2004) (describing the variety of social insurance systems). See
generally Robert G. Evans, Financing Health Care: Taxation and the Alternatives, in FUNDING HEALTH
CARE: OPTIONS FOR EUROPE 31 (Elias Mossialos et al. eds., 2002) (describing general revenue funding
systems).
17. For a comparison of the Canadian provincial health care systems, see HEALTH CAN., CANADA
HEALTH ACT ANNUAL REPORT, 2005–2006, at 15–193 (2006). Although all Canadian provinces cover
hospital care and physicians’ services, they vary significantly in their coverage of pharmaceuticals. See
VALÉRIE PARIS & ELIZABETH DOCTEUR, OECD, PHARMACEUTICAL PRICING AND REIMBURSEMENT POLICIES IN
CANADA 17–20 (2007). All residents of Quebec who do not have private drug coverage must sign up for
the public plan, while in Ontario, coverage is much more limited. See id. at 20.
18. See SCOTT L. GREER, TERRITORIAL POLITICS AND HEALTH POLICY: UK HEALTH POLICY IN COMPARA-
TIVE PERSPECTIVE 63–71 (2004).
19. See Special Issue, Legacies and Latitude in European Health Policy, 30 J. HEALTH POL. POL’Y &
L. 1 (2005).
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Chapter V of the German Social Code,20 for example, or the Canada Health
Act,21 or Titles XVIII and XIX of the Social Security Act in the United States,22
or the British National Health Services Act of 2006.23 These framework laws
are operationalized by more specific regulations and guidelines, such as Chapter
42 of the Code of Federal Regulations or the Medicare manuals in the United
States.24
These statutes, regulations, and guidelines, however, are often quite different
than criminal or regulatory public law. On the one hand, they include broad
statements of policy that rarely present justiciable issues, such as the non-
interference provision of the Medicare statute25 or the “comprehensive health
service” requirement of the National Health Services Act.26 On the other hand,
these statutes and regulations also contain detailed provisions governing pro-
gram eligibility or payment for or coverage of products and services that may or
may not create legal rights or obligations, but are primarily directed at guiding
program administration.27 In most instances they are interpreted and applied by
civil servants rather than lawyers.
Other bodies of domestic law also govern health care systems. Competition
or antitrust law plays an important role in many countries,28 as does private
health insurance regulation.29 Fraud and abuse law is very important in a few
countries and probably should be more important in others.30 Tax subsidies play
a major role in the United States health care system,31 and a lesser but not
20. Sozialgesetzbuch Gesetzliche Krankenversicherung V [SGB V] [Social Insurance Code] Dec.
20, 1988, Bundesgesetzblatt, Teil I [BGBl. I].
21. Canada Health Act, R.S.C., ch. C 6 (1985).
22. 42 U.S.C. §§ 1395–1396v (2000 & Supp. IV 2004).
23. National Health Services Act, 2006, c. 41 (Eng.), available at http://www.opsi.gov.uk/ACTS/
acts2006/20060041.htm.
24. See CENTERS FOR MEDICARE AND MEDICAID SERVICES, INTERNET-ONLY MANUALS (IOMS) (2007),
http://www.cms.hhs.gov/Manuals/IOM/list.asp.
25. “Nothing in this title . . . shall be construed to authorize any Federal officer or employee to
exercise any supervision or control over the practice of medicine or the manner in which medical
services are provided . . . .” 42 U.S.C. § 1395 (2000).
26. “The Secretary of State must continue the promotion in England of a comprehensive health
service designed to secure improvement—(a) in the physical and mental health of the people of
England, and (b) in the prevention, diagnosis and treatment of illness.” National Health Services Act,
2006, c. 41 § 1 (Eng.).
27. See, e.g., 42 U.S.C. § 1395ww(d)(7) (2000) (specifying that administrative and judicial review
are not available for certain inpatient hospital prospective payment determinations made under the
Medicare statute).
28. See, e.g., Timothy Stoltzfus Jost, Diane Dawson & André den Exter, The Role of Competition in
Health Care: A Western European Perspective, 31 J. HEALTH POL. POL’Y & L. 687 (2006).
29. See Timothy Stoltzfus Jost, Private or Public Approaches to Insuring the Uninsured: Lessons
from International Experience with Private Insurance, 76 N.Y.U. L. REV. 419 (2001).
30. See generally Niteesh K. Choudhry, Adalsteinn D. Brown & Sujit Choudhry, Health Care Fraud
and Gaming (unpublished manuscript, on file with author).
31. TIMOTHY STOLTZFUS JOST, DISENTITLEMENT? THE THREATS FACING OUR PUBLIC HEALTH-CARE PRO-
GRAMS AND A RIGHTS-BASED RESPONSE 32–34 (2003).
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insignificant role in other countries.32
But in general, lawyers and legal institutions, and more specifically the
courts, play a marginal role in the organization and function of most health care
financing systems. In only a few countries, notably Germany and the United
States, and increasingly in England and in the European Union, is there a
significant volume of litigation involving health care finance issues.33 In most
countries, complaints are presented through special complaint panels or through
ombudspersons, and disputes are settled through arbitration or administrative
tribunals.34 Where legal challenges are brought, they are brought under adminis-
trative or constitutional law and are rarely successful.35 The courts usually need
say little more than that a particular financing decision is political or discretion-
ary to end the matter.36 Administrators and politicians run the system; lawyers
and courts are at the periphery.
III. LAW’S CONTRIBUTION
If indeed law has little to contribute to the design, organization, or reform of
health care financing, this would not, of course, in itself stop law professors
32. See Elias Mossialos & Sarah M.S. Thomson, Voluntary Health Insurance in the European
Union, in FUNDING HEALTH CARE: OPTIONS FOR EUROPE 134–135 (Elias Mossialos et al. eds., 2002).
Australia, by contrast, imposes a tax penalty on wealthy persons who fail to purchase private health
insurance. See MELISSA HILLESS & JUDITH HEALY, HEALTH CARE SYSTEMS IN TRANSITION: AUSTRALIA 37
(2001).
33. See André den Exter, Patient Mobility in the European Union, in JUST MEDICARE: WHAT’S IN,
WHAT’S OUT, HOW WE DECIDE 335 (Colleen M. Flood ed., 2006) [hereinafter JUST MEDICARE]; Timothy
Stoltzfus Jost, Health Care Rationing in the Courts: A Comparative Study, 21 HASTINGS INT’L & COMP.
L. REV. 639 (1998); Christopher Newdick, Judicial Supervision of Health Resource Allocation—English
Experience, in READINGS IN COMPARATIVE HEALTH LAW AND BIOETHICS 59, 59 (Timothy Stoltzfus Jost ed.,
2d ed. 2007).
34. See, e.g., JUDITH ALLSOP & LINDA MULCAHY, REGULATING MEDICAL WORK, FORMAL AND INFORMAL
CONTROLS (1996); Diane Longley, Complaints After Wilson; Another Case of Too Little Too Late?, 5
MED. L. REV. 172, 175–76 (1997); Vyonne Göricke Nordlund & Lars Edgren, Patient Complaint
Systems in Health Care: A Comparative Study Between the Netherlands and Sweden, 6 EUR. J. HEALTH
L. 133 (1999).
35. See, e.g., Colleen M. Flood, Mark Stabile & Carolyn Tuohy, What Is in and out of Medicare?
Who Decides?, in JUST MEDICARE, supra note 33, at 15, 26–30 (“[B]etween 1985 and 2002 of the
thirty-three cases that have challenged health care policy [under the equality provision of the Canadian
Charter], only eleven have been successful. More specifically, of the cases that have challenged policies
limiting insured medical services only one has been upheld at the Supreme Court level.”).
36. Representative is the statement of Lord Justice Bridge in Ex parte Hincks, (1980) 1 B.M.L.R. 93,
97 (1980):
I feel extremely sorry for the particular applicants in this case who have to wait a long time,
not being emergency cases, for necessary surgery. They share that misfortune with thousands
up and down the country. I only hope that they have not been encouraged to think that these
proceedings offered any real prospects that this court could enhance the standards of the
National Health Service, because any such encouragement would be based upon manifest
illusion.
In fairness to the British courts, they have become somewhat more willing to intervene in Health
Services decisions in recent years, see Newdick, supra note 33, at 67–68, but world-wide, courts still
tend to see health services rationing decisions as largely nonjusticiable.
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from weighing in on the subject. Law professors have little respect for the
territorial boundaries of other disciplines. We are virtually all amateur econo-
mists; indeed some have made a career out of being amateur economists. Many
of us are quite happy to pontificate on philosophy, history, sociology, and, above
all, policy. One can easily imagine a law school program of study examining
health care systems that rarely touched on law.
However, I believe that if we as legal academics are honest with ourselves,
we do face the double conundrum just presented. First, does law make more
than a marginal contribution to discussions of health care financing, and second,
if it does, is this contribution solely at the domestic level?
I believe that law can contribute to the consideration of health care financing
and that law can make a contribution at a global level. The areas of law where
global law touches most directly on health care finance are international human
rights law, international trade law, international pharmaceutical regulation, and
comparative health law.
First, international human rights law speaks to issues of health care financing
and provision. Article 25 of the 1948 Universal Declaration of Human Rights
provides: “Everyone has the right to a standard of living adequate for the health
and well-being of himself and of his family, including food, clothing, housing
and medical care and necessary social services, and the right to security in the
event of . . . sickness, [and] disability . . . .”37
The International Covenant on Economic, Social, and Cultural Rights (IC-
ESCR) more specifically provides at Article 12: “The States Parties . . . recog-
nize the right of everyone to the enjoyment of the highest attainable standard of
physical and mental health.”38 The steps that signatories commit themselves to
taking to implement this right include public health protection measures and
achieving: “[T]he creation of conditions which would assure to all medical
service and medical attention in the event of sickness.”39
The ICESCR has been adopted by approximately 150 countries (although it
has not been ratified in the United States).40 The Covenant, however, only
requires each State Party “to take steps . . . to the maximum of its available
resources, with a view to achieving progressively the full realization of the
rights . . . .”41 The ICESCR is also supplemented by other regional human rights
conventions and conventions prohibiting discrimination against particular popu-
37. Universal Declaration of Human Rights, G.A. Res. 217A, at 71, U.N. GAOR, 3d Sess., 1st plen.
mtg., U.N. Doc. A/810 (Dec. 12, 1948).
38. International Covenant on Economic, Social, and Cultural Rights, art. 12, Dec. 16, 1966, 993
U.N.T.S. 3 [hereinafter ICESCR].
39. Id. art. 12.2(d).
40. See OFFICE OF THE U.N. HIGH COMM’R FOR HUMAN RIGHTS, STATUS OF RATIFICATIONS OF THE
PRINCIPAL HUMAN RIGHTS TREATIES AS OF 9 JUNE 2004 (2004), available at http://www.unhchr.ch/pdf/
report.pdf.
41. ICESCR, supra note 38, at art. 2.1.
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lations, such as women or children.42
What are the implications of human rights law for the financing of health
care? The courts of several countries, including South Africa, India, and Venezu-
ela, have in specific instances recognized an enforceable right to health care
under their domestic constitution43 and in some instances, the existence of a
broader international human right to health care.44 The human right to health
care is also used rhetorically to argue for increased health care services. But I
know of no international tribunal that has brought about the expansion of
availability of health care services through the application of human rights law,
or of a domestic court that has done so by relying solely on international, as
opposed to domestic, human rights law.45 Indeed, although approximately
two-thirds of the world’s constitutions recognize a right to health or health care,
constitutional provisions seem to have little relationship with national commit-
ments of resources to health care.46
Second, international trade law is having an increasingly significant influence
on health care systems. This is most obviously true in the European Union,
where a series of decisions of the European Court of Justice have allowed
residents of one E.U. country to receive health care services in another member
country at the cost of their own health care systems when those services are not
adequately available in their own country.47 European Union free trade and
competition law is also increasingly constraining the ability of member nations
to regulate private health insurance.48
While the European Union presents the most obvious example of interna-
tional trade law influencing health care systems, it is not difficult to find other
42. See Eleanor D. Kinney, The International Human Right to Health: What Does This Mean for
Our Nation and World?, 34 IND. L. REV. 1457, 1460 (2001).
43. See State of West Bengal [W.B.] v. Paschim Banga Khet Mazdoor Samity, 1996 A.I.R. 2426
(S.C.) (India) (right to provision of “adequate medical facilities”); Minister of Health & Others v
Treatment Action Campaign & Others (2002) (5) SA 721 (CC) (S. Afr.) (obligation of government to
provide medication that prevents mother-to-child transmission of AIDS); Bermúdez v. Ministerio de
Sanidad y Asistencia Social, Case No. 15.789, Decision No. 916 (Venez. 1999) (access to antiretroviral
drugs); see also Lisa Forman, Ensuring Reasonable Health: Health Rights, the Judiciary, and South
African HIV/AIDS Policy, 33 J.L. MED. & ETHICS 711 (2005).
44. Both Bermúdez and the Treatment Action Campaign cases, for example, refer to the ICESCR.
See supra note 43.
45. The U.N. Human Rights Commission, interpreting the ICESCR’s companion, the International
Covenant on Civil and Political Rights (ICCPR), Dec. 16, 1966, 999 U.N.T.S. 171, has held that the
Peruvian law prohibiting abortion violated the ICCPR, U.N. Human Rights Comm., Comm’n on
K.N.L.H. v. Peru, ¶¶ 2.1–2.3, 6.5–6.6, U.N. Doc. A/61/40 (II) (Nov. 13, 2002), while the European
Court of Human Rights, applying the Council of Europe’s Convention for the Protection of Human
Rights and Fundamental Freedoms, Nov. 4, 1950, 213 U.N.T.S. 221, recently ruled that Poland had an
obligation to provide a means of reviewing a denial of abortion for health reasons, Tysiąc v. Poland,
App. No. 5410/03, Eur. Ct. H.R. (2007), available at http://www.echr.coe.int/eng. Neither case estab-
lishes a broader right to health care financing.
46. See Eleanor D. Kinney & Brian Alexander Clark, Provisions for Health and Health Care in the
Constitutions of the Countries of the World, 37 CORNELL INT’L L.J. 285, 291, 295 (2004).
47. See den Exter, supra note 33.
48. See Jost, Dawson & den Exter, supra note 28, at 695–99.
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examples. The protections offered to drug patents by the 1994 Trade-Related
Aspects of Intellectual Property Rights (TRIPS) agreement, for example, have
created a major barrier to access to affordable pharmaceuticals for developing
countries, which was only partially addressed by the Doha agreement.49 The
Australia-United States Free Trade Agreement provides United States drug
companies with the right to challenge decisions of the Australian Pharmaceuti-
cal Benefits Scheme, which has raised concerns about the ability of Australia to
control drug prices.50 The implications of NAFTA for the regulation of private
health insurance in Canada following the 2005 Chaoulli decision, which found
a right to purchase private health insurance under the Quebec Charter,51 is a
source of concern for Canadian legal commentators.52
Third, and closely related, regulation of the sale of pharmaceuticals is
increasingly taking place on an international scale. While this is primarily an
issue of health care regulation rather than the financing of health care, it is
ultimately likely to have implications for the ability of countries to control a
major segment of their health care expenditures. For example, when the Euro-
pean Medicines Agency approved Viagra in 1998, the British National Health
Service was caught by surprise and, in its hurry to develop a coverage policy,
ended up being sued by Pfizer under domestic and European law.53
Fourth, perhaps the most useful contribution of global law to this area will be
through comparative rather than international law. Two years ago, I led a team
of scholars from eight nations who examined health care coverage determina-
tions in the public health care systems of their countries, one goal of which was
to examine the role that administrative procedure played in these determina-
tions.54 Our conclusion was that the role of legal institutions and procedure is
49. TRIPS is an international agreement administered by the World Trade Organization that imposes
on its signatory countries obligations to protect intellectual property rights, including the patent rights
of pharmaceutical companies. The modifications to the agreement reached in 2001 at a meeting at Doha
gave developing countries greater flexibility in assuring their residents rights to essential medicines. See
Frederick M. Abbott, The WTO Medicines Decison: World Pharmaceutical Trade and the Protection of
Public Health, 99 AM. J. INT’L L. 317 (2005); M. Gregg Bloche & Elizabeth R. Jungman, Health Policy
and the WTO, 31 J.L. MED. & ETHICS 529, 535–36 (2003); Kevin Outterson, Pharmaceutical Arbitrage:
Balancing Access and Innovation in International Prescription Drug Markets, 5 YALE J. HEALTH POL’Y
L. & ETHICS 193, 223–30 (2005).
50. See Peter Sainsbury, Australia-United States Free Trade Agreement and the Australian Pharma-
ceutical Benefits Scheme, 4 YALE J. HEALTH POL’Y L. & ETHICS 387 (2004).
51. Chaoulli v. Attorney General of Quebec, [2005] 1 S.C.R. 791, 2005 SCC 35 (Can.).
52. Tracey Epps & David Schneiderman, Opening Medicare to Our Neighbours or Closing the Door
on a Public System? International Trade Law Implications of Chaoulli v. Quebec, in ACCESS TO CARE,
ACCESS TO JUSTICE: THE LEGAL DEBATE OVER PRIVATE HEALTH INSURANCE IN CANADA 369 (Colleen M.
Flood et al. eds., 2005); Mark Crawford, Interactions: Trade Policy and Healthcare Reform After
Chaoulli v. Quebec, 1 HEALTHCARE POLICY / POLITIQUES DE SANTÉ (2), 90 (2006).
53. Ex parte Pfizer, Ltd., (1999) 3 C.M.L.R. 875 (Q.B.) (Eng.).
54. See generally HEALTH CARE COVERAGE DETERMINATIONS: AN INTERNATIONAL COMPARATIVE STUDY
(Timothy Stoltzfus Jost ed., 2005) [Hereinafter HEALTH CARE COVERAGE].
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significant.55 A number of articles in a 2005 special issue of the Journal of Law,
Medicine and Ethics edited by Colleen Flood, Lance Gable, and Larry Gostin
on legislating and litigating health care rights also comparatively examined the
role law plays in determining health care coverage in health care systems.56
There is useful work being done and to be done in this area.
Moreover, the comparative study of health care systems is inherently of
interest. It offers students a useful perspective from which to view our own
badly flawed American health care system. Hopefully, as some of our students
move on to become policy-makers, they will take these lessons with them.
Lawyers also have skills that they can bring to comparative policy studies.
Lawyers are trained to be experts in procedure, for example, and every health
care system needs procedures for getting things done. Lawyers are taught to
think clearly and logically about solving problems and are free of much of the
jargon and ideological baggage that burdens other disciplines. Finally, lawyers
are supposed to be concerned about justice, and every health care system can
use more justice in addressing disparities between the rich and the poor, for
example, or assuring equal access for racial and ethnic minorities.57
CONCLUSION
In the end, there are good reasons to conclude that a global health law
program should address health care financing. Even though health care financ-
ing law is primarily domestic in its orientation and is not primarily driven by
legal considerations, international human rights law, trade law, and pharmaceuti-
cal regulation, at least, do affect health care financing at a global level.
Comparative examination of health care financing law is also inherently interest-
ing and may make a contribution toward shaping domestic health policy.
We as lawyers, and this new program, do have a useful contribution, however
modest, to make to the study of global health care organization and financing
law.
55. See Timothy Stolzfus Jost, Conclusion to HEALTH CARE COVERAGE, supra note 54, at 261–62.
Legal rules, for example, determine who can initiate coverage determinations, appeal adverse determina-
tions, and even have a seat at the table when determinations are made. These factors in turn affect the
likelihood that coverage determinations will favor coverage of new technologies.
56. Symposium, Legislating and Litigating Health Care Rights Around the World, 33 J.L. MED. &
ETHICS (SPECIAL ISSUE) 636–738 (2005).
57. See JOST, supra note 15, at 177–81.
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